News

October 16, 2026

Our Phase IIa trial of N-desmethyl-clobazam in patients with peripheral neuropathic pain, just published in the European Journal of Pain, shows a promising link between drug exposure and pain relief, with good tolerability.
Read the article

August 30, 2024, Geneva

Iremis therapeutics is incorporated.